Ex parte MATTOX - Page 7




          Appeal No. 94-4487                                                          
          Application No. 08/006,021                                                  


               Appellant cites EXAMPLE 3 of the present specification to              
          demonstrate that, contrary to the teachings of the prior art,               
          salts of magnesium, nickel, zinc, manganese, sodium and calcium             
          do not stabilize dilute solutions of CMI, whereas the ferric salt           
          does.  However, the relevant issue is whether, based on the                 
          teachings of the prior art, the claimed invention utilizing                 
          ferric salt as a stabilizer would have been unobvious to one of             
          ordinary skill in the art.  Manifestly, the applied prior art               
          teaches the use of the claimed ferric salt as a stabilizer in a             
          dilute solution, and EXAMPLE 3 does not evidence unexpected                 
          results by demonstrating that the claimed ferric salt operates as           
          taught by the prior art.  While appellant's specification data              
          may be unexpected to the extent that it demonstrates certain                
          salts are ineffective, this is not relevant to the claimed                  
          subject matter.                                                             
               In conclusion, based on the foregoing, the examiner's                  
          rejection under 35 U.S.C. § 112, first paragraph, is reversed.              
          The examiner's rejection under 35 U.S.C. § 103 is affirmed.  The            
          examiner's decision is affirmed-in-part.                                    
               No time period for taking any subsequent action in                     
          connection with this appeal may be extended under 37 CFR                    
          § 1.136(a).                                                                 
                                  AFFIRMED-IN-PART                                    
                                         -7-                                          




Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007